366 related articles for article (PubMed ID: 6296653)
1. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
Woodcock EA; Johnston CI
Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
[TBL] [Abstract][Full Text] [Related]
2. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
Snavely MD; Insel PA
Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
[TBL] [Abstract][Full Text] [Related]
3. Alpha-adrenergic inhibition of renal cortical adenylate cyclase.
Woodcock EA; Johnston CI; Olsson CA
J Cyclic Nucleotide Res; 1980; 6(4):261-9. PubMed ID: 6110680
[TBL] [Abstract][Full Text] [Related]
4. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
5. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
7. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung.
Latifpour J; Jones SB; Bylund DB
J Pharmacol Exp Ther; 1982 Dec; 223(3):606-11. PubMed ID: 6292392
[TBL] [Abstract][Full Text] [Related]
9. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
[TBL] [Abstract][Full Text] [Related]
10. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine binding to CNS adrenergic receptors.
U'Prichard DC; Snyder SH
J Supramol Struct; 1978; 9(2):189-206. PubMed ID: 219293
[TBL] [Abstract][Full Text] [Related]
12. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
Williams LT; Gore TB; Lefkowitz RJ
J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
[TBL] [Abstract][Full Text] [Related]
14. Interactions of agonists with platelet alpha 2-adrenergic receptors.
Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
16. The alpha 2-adrenergic receptor: multiple affinity states and regulation of a receptor inversely coupled to adenylate cyclase.
U'Prichard DC; Mitrius JC; Kahn DJ; Perry BD
Adv Biochem Psychopharmacol; 1983; 36():53-72. PubMed ID: 6134436
[No Abstract] [Full Text] [Related]
17. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
Alexander RW; Cooper B; Handin RI
J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
[TBL] [Abstract][Full Text] [Related]
18. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
19. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
Sanae F; Miyamoto K; Koshiura R
Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
[TBL] [Abstract][Full Text] [Related]
20. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
